Related Experiment Video

Updated: May 11, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K

Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications

Shuzhen Mao1, Junyan Li2, Jiahui Huang3

  • 1Department of Pharmacy, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Frontiers in Oncology
|April 18, 2025
PubMed

Insights

MicroRNAs, specifically miR-506, show tumor-suppressive effects in many cancers. This review explores how miR-506 functions in cancer, highlighting its therapeutic potential against cancer progression and drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer remains a leading cause of death due to challenges in early detection, drug resistance, and treatment side effects.
  • MicroRNAs (miRNAs) are key regulators in cancer development, with miR-506 identified as a significant tumor suppressor.
  • The competing endogenous RNA (ceRNA) network plays a crucial role in regulating gene expression in cancer.

Purpose of the Study:

  • To review the regulatory mechanisms of miR-506 in common cancers.
  • To investigate the role of miR-506 within the ceRNA network.
  • To explore miR-506's potential as a therapeutic target for overcoming cancer drug resistance.

Main Methods:

  • Literature review of studies on miR-506 in various cancer types.
  • Analysis of miR-506's involvement in cancer cell proliferation, apoptosis, and migration.
  • Examination of miR-506's function in the ceRNA network and its impact on therapeutic resistance.

Main Results:

  • miR-506 exhibits tumor-suppressive properties across multiple cancer types.
  • miR-506 influences cancer cell proliferation, apoptosis, and migration.
  • The ceRNA network is a key mechanism through which miR-506 exerts its effects.

Conclusions:

  • miR-506 is a critical regulator with significant tumor-suppressive functions in cancer.
  • Targeting miR-506 offers a promising strategy for novel cancer therapies.
  • miR-506 may play a vital role in overcoming resistance to current cancer treatments.
Keywords:
cancercircular RNAsdrug resistancelong non-coding RNAsmicroRNA-506

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.2K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K